04/15/2014 - 11:00am

Actavis on Tuesday announced that it has entered into an agreement with Mylan and Famy Care to settle all outstanding patent litigation related to Mylan's generic version of Generess FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets).

04/15/2014 - 10:49am

Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by Design, on Tuesday announced that it has entered into a global licensing agreement with Mylan for its leading inhaled respiratory products, PSX1001 and PSX1050.

04/15/2014 - 10:43am

Mylan announced that it has launched eszopiclone tablets in 1 mg, 2 mg and 3 mg form.

04/15/2014 - 10:39am

Supervalu's Save-A-Lot on Monday announced plans for a new 140,000-sq.-ft. food distribution center in Aurora, Colo., in June 2014.

04/15/2014 - 10:34am

99 Cents Only Stores on Tuesday announced its financial results for the shortened fiscal year 2014 that began on March 31, 2013 and ended January 31, 2014, consisting of 44 weeks.

04/15/2014 - 10:26am

The Food and Drug Administration on Friday announced a meeting of the Nonprescription Drugs Advisory Committee on May 2 to discuss the potential switch of Merck's Singulair Allergy tablets.

04/15/2014 - 10:15am

Greenstone, a generic pharmaceutical subsidiary of Pfizer, announced the introduction of amlodipine besylate/atorvastatin calcium tablets to its roster of products.

04/15/2014 - 10:07am

Prestige Brands on Tuesday announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia.